After so many years studying procrastination, Joseph Ferrari has some thoughts about why you can’t seem to get anything done ...

Buy: Anthropic exposure via its likely IPO/secondary path (e.g., IPO allocation or liquid proxy like AI-safety/compute beneficiaries). Rationale: Anthropic is pushing “slow/pause” policy while still ...

Hakeem Oluseyi, a science educator and physicist, charted his “unlikely journey from the street to the stars” in his memoir, “A Quantum Life” (2021). He brings the same relatable style to “Why Do We ...

Recursive self-improvement is not a future event. In practical form, it has already begun. The "George Jetson Button" is the approval ritual humans perform while AI systems do more of the actual work.

There was a time in the late 2000s and early 2010s when seeing a “Sign in with Google” option on a new website or service was a sign of relief for me. I didn’t need to create a new username and ...

I was 11 years old when I learned that I talk funny. A new teacher who didn’t share my Boston accent was surprised by the way I said “kindergarten.” She mockingly repeated my pronunciation back to me: ...

Has anyone ever poked fun at the way you talk, how you pronounce a word or phrase? For Philadelphians, it might be “wooder” “caw-fee” “bee-yoo-dee-full” or “jeet?” But all of us have some kind of ...

In “Why Do We Exist?” Hakeem Oluseyi explores how life may have emerged to move energy through matter—and why Earth is the perfect setting. The following is an excerpt from “Why Do We Exist?: The Nine ...

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the best medical AI stocks to buy now. On March 31, Recursion moved to supercharge its AI-driven drug discovery platform through an expanded ...

Joe Supan is a senior writer for CNET covering home technology, broadband, and moving. Prior to joining CNET, Joe led MyMove's moving coverage and reported on broadband policy, the digital divide, and ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Recursion Pharmaceuticals, Inc. before investing. In this article, we go over a ...